4//SEC Filing
Koenig Sheldon L. 4
Accession 0001628280-22-016705
CIK 0001434868other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:48 PM ET
Size
5.4 KB
Accession
0001628280-22-016705
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2022-06-07+91,000→ 91,000 totalExercise: $6.20Exp: 2032-06-07→ Common Stock (91,000 underlying)
Footnotes (1)
- [F1]Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001766524
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:48 PM ET
- Size
- 5.4 KB